Charles Craft
Family Medicine · Barling, ARNPI 1013945138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 466 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,362 and has fallen 99.1% since, to $21 in 2025. Among family medicine clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 466 payments — averaging $13.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$787
- AstraZeneca$737
- AbbVie$729
- GSK$685
- Amgen$494
- Boehringer Ingelheim$446
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,297100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 52 | $787 |
| AstraZeneca(2 entities) | 38 | $737 |
| AbbVie(2 entities) | 66 | $729 |
| GSK | 55 | $685 |
| Amgen | 36 | $494 |
| Boehringer Ingelheim | 33 | $446 |
| Novo Nordisk | 23 | $368 |
| Abbott | 18 | $301 |
| Pfizer | 25 | $289 |
| Johnson & Johnson | 16 | $201 |
| Biohaven Pharmaceuticals, Inc. | 18 | $173 |
| Lilly USA, LLC | 9 | $130 |
| Upsher-smith Laboratories LLC | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $96 |
| Esperion Therapeutics, Inc. | 7 | $91 |
| Novartis | 6 | $87 |
| Teva Pharmaceuticals USA, Inc. | 6 | $86 |
| Avanir Pharmaceuticals, Inc. | 6 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Bayer | 4 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Sanofi Pasteur Inc. | 1 | $30 |
| Merck | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $12 |
| Mylan Specialty L.p. | 1 | $11 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$6,303 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 18 | $16,497 |
| OzempicSemaglutide | 12 | $11,689 |
| Felbamate | 13 | $4,240 |
| Lacosamide | 14 | $1,857 |
| Trazodone Hcl | 28 | $711 |
| Potassium Chloride | 11 | $597 |
| Levothyroxine Sodium | 52 | $586 |
| Sertraline Hcl | 13 | $450 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $406 |
| Indapamide | 12 | $379 |
| Gabapentin | 23 | $360 |
| Liothyronine Sodium | 13 | $357 |
| Montelukast Sodium | 13 | $337 |
| Quetiapine Fumarate | 32 | $325 |
| Atorvastatin Calcium | 18 | $306 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $729 | $16,49718 claims |
| Novo NordiskOzempic | $368 | $11,68912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Barling
- Glenn GibbonsFort Smith$179K
- Hetal PatelParagould$147K
- David GersonSherwood$119K
- Scott MusickBentonville$102K
- Broderick EatonWynne$49K
- Craig LevoyBentonville$30K
- Allen BeachyFort Smith$21K
- Hunter CarringtonHot Springs$20K
- Harold BettonLittle Rock$18K
- Thad HardinConway$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.